Kilitch Drugs (India) Ltd.

•

kilitch.comBSE: 524500NSE: KILITCH

Market Cap₹ 630 Cr.

Current Price

High / Low₹ 220 / 117

Stock P/E21.0

Book Value₹ 80

Price to Book1.60

Dividend Yield0.00 %

ROCE14.5 %

ROE12.3 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 50.9% CAGR over last 5 years
Latest quarter profit grew 769.6% YoY, showing strong momentum
Company has delivered good sales growth of 28.0% CAGR over last 5 years
Company has consistently been profitable over the last 5 years
Company comfortably covers its interest (7.1x coverage)
Attractively priced for its growth - PEG of 0.4

CONS

Receivables are growing faster than sales - a possible quality concern
A large part of profit comes from other income (29.1% of PBT)
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.59x)
Free cash flow has been persistently negative
Total debt has risen sharply - up 79.5% year on year

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	3620.70	2139.42	20263.10	1191.00	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	KILITCH	180.10	20.95	629.66	0.00	19.67	769.58	448.79	940.31	14.50	6.54

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	37	41	32	45	33	47	56	61	43	49	54	90	449
	30	33	30	38	32	41	47	47	40	44	48	67	439
Operating Profit	6	9	2	7	2	6	9	15	3	5	6	22	10
OPM %	16.90%	20.92%	7.14%	15.80%	4.96%	12.85%	15.56%	23.84%	7.56%	10.30%	11.43%	24.71%	2.15%
	1	0	3	0	3	5	2	2	3	7	2	0	29
Interest	2	2	2	1	2	0	1	2	2	1	1	1	9
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	11
Profit before Tax	4	7	3	5	2	10	8	14	3	9	6	20	39
Tax %	31.24%	24.93%	38.30%	30.57%	93.33%	16.81%	32.00%	26.23%	34.49%	14.47%	22.86%	26.37%	49.08%
Net Profit	0	0	0	0	0	9	6	10	2	8	4	15	20
	2.15	2.93	1.85	2.24	0.83	5.36	3.71	6.47	1.88	4.97	2.50	4.24	0.83

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	29	51	82	53	69	114	140	154	198	235	641
	29	46	76	53	63	104	122	130	167	198	598
Operating Profit	-1	5	6	-0	5	11	18	24	32	37	43
OPM %	-1.89%	10.39%	7.30%	-0.01%	7.76%	9.19%	12.70%	15.72%	16.01%	15.85%	6.71%
	1	3	5	5	3	3	3	4	11	11	38
Interest	0	0	1	1	1	1	5	6	5	6	13
Depreciation	10	2	2	2	2	2	4	3	3	4	14
Profit before Tax	-9	6	9	2	5	10	12	19	34	39	74
Tax %	4.57%	15.71%	55.40%	47.61%	26.43%	35.37%	31.06%	29.86%	27.66%	23.68%	36.47%
Net Profit	-9	5	4	1	4	6	8	14	25	30	47
EPS	0.00	0.00	0.00	0.00	2.37	4.73	6.71	9.08	16.60	8.63	—
Dividend Payout %	0.00%	13.33%	20.05%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: 27%
5 Years:: 28%
3 Years:: 19%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: 52%
3 Years:: 42%

STOCK PRICE CAGR

10 Years:: 27%
5 Years:: 17%
3 Years:: 24%
1 Year:: 1%

RETURN ON EQUITY

10 Years:: 5%
5 Years:: 9%
3 Years:: 11%
Last Year:: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	13	14	15	15	15	16	16	16	16	35
Minority Interest	0	1	2	2	2	1	-1	-1	-2	-3
	87	95	105	102	111	121	131	160	186	244
	1	1	9	13	15	20	22	32	49	89
Trade Payables	6	8	4	7	54	43	41	26	54	80
	4	8	7	3	4	8	9	5	6	8
Total Liabilities	110	126	143	142	202	208	218	237	310	453
	33	33	32	32	30	65	64	62	64	67
Capital Work in Progress	1	3	20	30	65	3	4	6	47	140
	53	56	53	52	60	71	62	72	72	75
	3	3	5	6	4	5	2	4	15	12
	0	0	0	0	0	0	0	63	85	120
Cash & Bank	2	5	8	3	13	10	20	20	10	17
	19	26	24	21	30	54	66	10	16	23
Total Assets	110	126	143	142	202	208	218	237	310	453

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1	1	4	7	47	8	7	-2	18	24
Cash from Investing	-2	-4	-14	-10	-38	-15	8	-8	-40	-100
Cash from Financing	-0	6	17	1	2	7	-1	9	13	82
	-0	2	3	-5	10	-2	10	-1	-9	6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	-6.72	3.75	2.49	0.55	2.37	4.73	6.71	9.08	16.60	8.63
Book Value (₹)	75.44	78.86	78.11	75.85	81.82	87.43	93.85	109.40	125.59	79.89
Dividend per Share (₹)	0.00	0.50	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	0.32	2.56	1.87	0.90	1.82	2.73	3.72	5.15	8.53	9.47
PROFITABILITY
Operating Margin %	2.07%	16.74%	13.68%	8.52%	11.62%	11.74%	14.79%	15.72%	16.01%	15.85%
Net Margin %	-30.98%	10.07%	4.64%	1.58%	5.48%	5.44%	5.93%	8.79%	12.58%	12.53%
ROE %	-8.59%	4.95%	3.36%	0.71%	3.09%	4.73%	5.86%	8.43%	13.20%	12.26%
ROCE %	-8.69%	6.08%	7.59%	1.95%	4.40%	7.26%	10.26%	13.30%	17.31%	14.50%
	-7.86%	4.36%	2.85%	0.59%	2.19%	3.03%	3.89%	5.97%	9.11%	7.73%
EFFICIENCY
Debtor Days	197	126	89	121	103	103	125	139	136	159
Inventory Days	33	19	17	35	24	14	9	7	18	21
Payable Days	152	94	46	72	297	269	204	154	139	194
	78	51	60	84	-170	-153	-70	-8	15	-14
FINANCIAL HEALTH
Debt to Equity (x)	0.01x	0.01x	0.08x	0.11x	0.12x	0.15x	0.15x	0.18x	0.24x	0.32x
Interest Coverage (x)	-58.98x	15.68x	14.25x	2.71x	6.84x	8.22x	3.36x	4.21x	7.48x	7.14x
	4.15x	4.22x	3.23x	2.54x	1.10x	1.65x	1.84x	2.27x	2.06x	1.83x
GROWTH
Revenue Growth %	36.54%	78.04%	61.71%	-35.36%	28.51%	66.71%	22.20%	10.58%	28.47%	18.74%
Operating Profit Growth %	139.20%	1340.09%	31.67%	-59.73%	75.65%	68.00%	53.96%	39.19%	49.28%	13.21%
Net Profit Growth %	20.56%	157.96%	-25.67%	-78.01%	347.34%	64.97%	33.30%	63.90%	83.72%	18.28%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	35.41%	82.86%	-48.03%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	42.02x	10.65x	14.78x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	3.56x	2.88x	1.60x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	22.23x	14.47x	10.66x

Shareholding Pattern

Numbers in percentages

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	69.23	69.23	69.23	69.23	63.77	63.77	63.77	63.77
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.12
DIIs	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	30.76	30.77	30.77	30.76	36.23	36.23	36.22	36.11

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-27

Shareholders meeting

2026-08-27 - Kilitch Drugs (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 27, 2026

2026-08-27

Shareholders meeting

2026-08-27 - Kilitch Drugs (India) Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 27, 2026

2026-08-18

Monitoring Agency Report

2026-08-18 - We are submitting herewith monitoring agency report

2026-08-18

Copy of Newspaper Publication

2026-08-18 - Kilitch Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-13

Outcome of Board Meeting

2026-08-13 - Kilitch Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-04

Copy of Newspaper Publication

2026-08-04 - Kilitch Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-01

Updates

2026-08-01 - Kilitch Drugs (India) Limited has informed the Exchange regarding 'AGM Notice and Annual Report - Physical Intimation to Shareholders'.

2026-08-01

Updates

2026-08-01 - Kilitch Drugs (India) Limited has informed the Exchange regarding 'Intimation of Book Closure for the purpose of AGM'.

2026-08-01

Shareholders meeting

2026-08-01 - Kilitch Drugs (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 27, 2026

News

Recent coverage and analyst commentary for KILITCH

Loading news…

🤖

AI Stock Analyst

Kilitch Drugs (India) Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

3620.70

2139.42

20263.10

1191.00

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

KILITCH

180.10

20.95

629.66

0.00

19.67

769.58

448.79

940.31

14.50

6.54

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

449

439

Operating Profit

OPM %

16.90%

20.92%

7.14%

15.80%

4.96%

12.85%

15.56%

23.84%

7.56%

10.30%

11.43%

24.71%

2.15%

Interest

Depreciation

Profit before Tax

Tax %

31.24%

24.93%

38.30%

30.57%

93.33%

16.81%

32.00%

26.23%

34.49%

14.47%

22.86%

26.37%

49.08%

Net Profit

2.15

2.93

1.85

2.24

0.83

5.36

3.71

6.47

1.88

4.97

2.50

4.24

0.83

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

114

140

154

198

235

641

104

122

130

167

198

598

Operating Profit

-1

-0

OPM %

-1.89%

10.39%

7.30%

-0.01%

7.76%

9.19%

12.70%

15.72%

16.01%

15.85%

6.71%

Interest

Depreciation

Profit before Tax

-9

Tax %

4.57%

15.71%

55.40%

47.61%

26.43%

35.37%

31.06%

29.86%

27.66%

23.68%

36.47%

Net Profit

-9

EPS

0.00

2.37

4.73

6.71

9.08

16.60

8.63

—

Dividend Payout %

0.00%

13.33%

20.05%

0.00%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

Minority Interest

-1

-2

-3

105

102

111

121

131

160

186

244

Trade Payables

Total Liabilities

110

126

143

142

202

208

218

237

310

453

Capital Work in Progress

140

120

Cash & Bank

Total Assets

110

126

143

142

202

208

218

237

310

453

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-2

Cash from Investing

-2

-4

-14

-10

-38

-15

-8

-40

-100

Cash from Financing

-0

-1

-0

-5

-2

-1

-9

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

-6.72

3.75

2.49

0.55

2.37

4.73

6.71

9.08

16.60

8.63

Book Value (₹)

75.44

78.86

78.11

75.85

81.82

87.43

93.85

109.40

125.59

79.89

Dividend per Share (₹)

0.00

0.50

0.00

Cash EPS (₹)

0.32

2.56

1.87

0.90

1.82

2.73

3.72

5.15

8.53

9.47

PROFITABILITY

Operating Margin %

2.07%

16.74%

13.68%

8.52%

11.62%

11.74%

14.79%

15.72%

16.01%

15.85%

Net Margin %

-30.98%

10.07%

4.64%

1.58%

5.48%

5.44%

5.93%

8.79%

12.58%

12.53%

ROE %

-8.59%

4.95%

3.36%

0.71%

3.09%

4.73%

5.86%

8.43%

13.20%

12.26%

ROCE %

-8.69%

6.08%

7.59%

1.95%

4.40%

7.26%

10.26%

13.30%

17.31%

14.50%

-7.86%

4.36%

2.85%

0.59%

2.19%

3.03%

3.89%

5.97%

9.11%

7.73%

EFFICIENCY

Debtor Days

197

126

121

103

125

139

136

159

Inventory Days

Payable Days

152

297

269

204

154

139

194

-170

-153

-70

-8

-14

FINANCIAL HEALTH

Debt to Equity (x)

0.01x

0.08x

0.11x

0.12x

0.15x

0.18x

0.24x

0.32x

Interest Coverage (x)

-58.98x

15.68x

14.25x

2.71x

6.84x

8.22x

3.36x

4.21x

7.48x

7.14x

4.15x

4.22x

3.23x

2.54x

1.10x

1.65x

1.84x

2.27x

2.06x

1.83x

GROWTH

Revenue Growth %

36.54%

78.04%

61.71%

-35.36%

28.51%

66.71%

22.20%

10.58%

28.47%

18.74%

Operating Profit Growth %

139.20%

1340.09%

31.67%

-59.73%

75.65%

68.00%

53.96%

39.19%

49.28%

13.21%

Net Profit Growth %

20.56%

157.96%

-25.67%

-78.01%

347.34%

64.97%

33.30%

63.90%

83.72%

18.28%

0.00%

35.41%

82.86%

-48.03%

VALUATION

P/E (x)

0.00x

42.02x

10.65x

14.78x

P/B (x)

0.00x

3.56x

2.88x

1.60x

Dividend Yield %

0.00%

0.00x

22.23x

14.47x

10.66x

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

69.23

63.77

0.00

0.12

DIIs

0.00

Government

0.00

30.76

30.77

30.76

36.23

36.22

36.11

Kilitch Drugs (India) Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Kilitch Drugs (India) Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI